When Gov. Ron DeSantis gave an update on the latest recovery efforts from Hurricane Helene Wednesday in Madeira Beach, he was ...

According to the Centers for Disease Control and Prevention (CDC) more than 107,000 people in the United States died of a ...

Chicago and Cook County are on pace to see a drastic decline in opioid-related fatalities in 2024, keeping with a nationwide ...

Dry eye disease affects up to 15% of the U.S. population and is one of the largest markets in the ophthalmology field.

In a bioterrorism event, will this Peninsula company have the drug to save us? Its goal is to create the one drug to rule ...

Gilead Sciences said on Thursday it would donate about 5,000 vials of its antiviral drug remdesivir to the Rwanda Medical ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

Alberta’s controversial approach to the opioid crisis rejects harm reduction, including supervised consumption sites. Despite ...

The Food and Drug Administration (FDA) has granted Orphan Drug designation to LQT-1213, a first-in-class serum glucocorticoid regulated kinase 1 (SGK1) inhibitor, for the treatment of long QT syndrome ...

Hot on the tail of AstraZeneca’s Imfinzi, Bristol Myers Squibb’s PD-1/L1 inhibitor Opdivo has expanded its non-small cell lung cancer (NSCLC) net with an ...

The approval was based on data from the randomized, double-blind, placebo-controlled, phase 3 CheckMate -77T trial.

Targeted therapies for PsA are effective for reducing the use of symptomatic treatments, sick leave, and rates of hospitalization.